Company: INV
Filing Date: 2025-04-15
Form Type: S-1
Source: 0001628280-25-017890
Chunk: 235

Company: Innventure, Inc.
Filing Date: 2025-04-15
Form: S-1
Chunk 235
---
 directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by

law. Any indemnified person is also entitled, subject to certain limitations, to advancement, direct payment, or

reimbursement of reasonable expenses (including attorneys’ fees and disbursements) in advance of the final

disposition of the proceeding.

In addition, we have entered into separate indemnification agreements with our directors and officers. These

agreements, among other things, require us to indemnify our directors and officers for certain expenses, including

attorneys’ fees, judgments, fines, and settlement amounts incurred by a director or officer in any action or

proceeding arising out of their services as one of our directors or officers or any other company or enterprise to

which the person provides services at its request.

We also maintain a directors’ and officers’ insurance policy pursuant to which our directors and officers are

insured against liability for actions taken in their capacities as directors and officers. We believe these provisions in

the A&R Certificate of Incorporation and these indemnification agreements are necessary to attract and retain

qualified persons as directors and officers.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers,

or control persons, in the opinion of the SEC, such indemnification is against public policy as expressed in the

Securities Act and is therefore unenforceable.

Item 15. Recent Sales of Unregistered Securities

Series B Preferred Stock

On September 24, 2024, the Company entered into an investment agreement with Commonwealth Asset

Management LP (together with its assignee, “CWAM LP”), pursuant to which the Company sold CWAM LP an

aggregate of 750,000 shares of Innventure’s Series B Preferred Stock, in a private placement, at a price of $10.00

per share of Series B Preferred Stock, resulting in an aggregate purchase price of approximately $7.5 million before

deducting fees and other estimated offering expenses, which sale closed on October 2, 2024. CWAM LP is an

affiliate of the Sponsor.

On September 27, 2024, the Company entered into an investment agreement, substantially in the same form as

the investment agreement entered into with CWAM LP (collectively, the “Series B Investment Agreements”), with

certain purchasers (together with CWAM LP, the “Series B Investors”), pursuant to which the Company agreed to

issue and sell to